The use of ciprofol in patients with different body surface areas for anesthesia during thoracic pulmonary lobectomy and its impact on postoperative anesthesia recovery.

Status

Active, not recruiting

Phases

Phase 3

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2300078969

Enrollment

Unknown

Registered

2023-12-21

Start date

2024-01-01

Completion date

Unknown

Last updated

2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ciprofol metabolism

Interventions

Group ?:BSA 1.8?

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: ? Select 132 patients from the Department of Thoracic Surgery, Dalian Medical University Affiliated Second Hospital, who are prepared for elective lobectomy. ? Gender is not limited. ? Age range is 18-65 years old. ? BMI range is 18-30 kg/?. ? ASA classification is grade I to grade II. ? Estimated duration of surgery is 1-2 hours. ? No metabolic diseases, no arrhythmias, no significant dysfunction of important organs such as the heart, lungs, liver, and kidneys, and intact skin without skin diseases.

Exclusion criteria

Exclusion criteria: 1. Long-term use of psychotropic drugs. 2. Cognitive impairment. 3. Allergy to Ciprofol and its ingredients. 4. History of analgesic medication and alcohol addiction. 5. Patient transferred to ICU after surgery and did not recover normally to be transferred to the ward. 6. Recently had plans for pregnancy and breastfeeding. 7. Participated in other clinical trials within the past 3 months. 8. Refused to participate in this study.

Design outcomes

Primary

Measure	Time frame
Ciprofol metabolic time;Awakening time;Maintain the dosage of Ciprofol;	—

Countries

China

Contacts

Public ContactZhou Feng

The Second Hospital of Dalian Medical University

yingjunc@outlook.com+86 177 0987 1766

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026